{
    "clinical_study": {
        "@rank": "134472", 
        "arm_group": [
            {
                "arm_group_label": "Tramadol", 
                "arm_group_type": "Experimental", 
                "description": "100 mg of tramadol SC (single dose) = 2 mL"
            }, 
            {
                "arm_group_label": "Placebo", 
                "arm_group_type": "Placebo Comparator", 
                "description": "2 mL of a sterile solution SC"
            }
        ], 
        "brief_summary": {
            "textblock": "Tramadol is a centrally acting synthetic analgesic used to treat moderate to moderately\n      severe pain.  It has been previously evaluated as a method to reduce pain during labour, but\n      there is always some fear related to its effects (neonatal respiratory depression).  The\n      purpose of our study was to evaluate the efficacy of subcutaneous tramadol in regards to\n      pain during labour, duration of labour and neonatal outcomes."
        }, 
        "brief_title": "Tramadol for Labour Analgesia in Low Risk Primiparous Women", 
        "completion_date": {
            "#text": "June 2013", 
            "@type": "Actual"
        }, 
        "condition": "Pain During Labour", 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Gestational age between 37 and 40 6/7 weeks\n\n          -  Primiparous patient\n\n          -  Singleton\n\n          -  4 to 5 cms of dilation\n\n          -  Intact membranes or spontaneous rupture of membranes less than 2 hours\n\n          -  Fetus in a vertex presentation\n\n          -  Gynecoid pelvis by clinical examination\n\n        Exclusion Criteria:\n\n          -  Multiparous\n\n          -  Multiple pregnancies\n\n          -  Any pathology\n\n          -  Induction of labour with prostaglandins"
            }, 
            "gender": "Female", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "100", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "June 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01889979", 
            "org_study_id": "MHST2012-09"
        }, 
        "intervention": [
            {
                "arm_group_label": "Tramadol", 
                "description": "100 mg of Tramadol was applied in the forearm SC (single dose).", 
                "intervention_name": "Tramadol", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "Placebo", 
                "description": "2 ml of a sterile solution was applied in the forearm SC (single dose).", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Tramadol"
        }, 
        "is_fda_regulated": "No", 
        "keyword": [
            "Pain during labour", 
            "Duration of labour", 
            "Apgar score", 
            "Umbilical cord pH"
        ], 
        "lastchanged_date": "July 7, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Panama", 
                    "country": "Panama", 
                    "zip": "1439 zona 9A"
                }, 
                "name": "Saint Thomas Maternity Hospital"
            }
        }, 
        "location_countries": {
            "country": "Panama"
        }, 
        "number_of_arms": "2", 
        "official_title": "Tramadol for Labour Analgesia in Low Risk Primiparous Women. Double Blind, Randomized, Controlled Trial.", 
        "overall_official": [
            {
                "affiliation": "Saint Thomas Maternity Hospital", 
                "last_name": "Osvaldo Reyes, MD", 
                "role": "Principal Investigator"
            }, 
            {
                "affiliation": "Saint Thomas Maternity Hospital", 
                "last_name": "Riggie Castillo, MD", 
                "role": "Principal Investigator"
            }
        ], 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Panama: Ministry of Health", 
            "has_dmc": "No"
        }, 
        "phase": "Phase 3", 
        "primary_completion_date": {
            "#text": "May 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Pain during labour was evaluated using the Visual Analogue Scale during the first six hours after the application of the drug (tramadol or placebo).", 
            "measure": "Pain during labour", 
            "safety_issue": "No", 
            "time_frame": "6 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01889979"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Saint Thomas Hospital, Panama", 
            "investigator_full_name": "Osvaldo A. Reyes T.", 
            "investigator_title": "Coordinator of Research", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "The duration of labour in minutes (all patients were admitted with 4-5 cms of dilation), comparing both groups.", 
                "measure": "Duration of labour", 
                "safety_issue": "No", 
                "time_frame": "12 hours"
            }, 
            {
                "description": "Apgar score at minute one and five and umbilical cord pH were evaluated and compared between both groups.", 
                "measure": "Neonatal outcomes", 
                "safety_issue": "Yes", 
                "time_frame": "48 hours"
            }, 
            {
                "description": "Maternal respiratory depression, headaches, nausea and dizziness were evaluated in both groups.", 
                "measure": "Side effects", 
                "safety_issue": "Yes", 
                "time_frame": "48 hours"
            }, 
            {
                "description": "Maximum dose of oxytocin (mU/min) required to have regular uterine contractions.", 
                "measure": "Requirements of oxytocin", 
                "safety_issue": "No", 
                "time_frame": "12 hours"
            }
        ], 
        "source": "Saint Thomas Hospital, Panama", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Saint Thomas Hospital, Panama", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 2012", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver, Investigator, Outcomes Assessor), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}